Kista Nabothi

01Pathophysiology

The cervix contains two types of epithelium. The endocervical canal is lined by columnar epithelium composed of mucin-secreting glandular cells. The ectocervix is covered by stratified squamous epithelium. The junction where these two epithelia meet is called the squamocolumnar junction (SCJ), and the area surrounding it is known as the transformation zone.

Throughout a woman's life, the position of the SCJ shifts. Under the influence of estrogen (puberty, pregnancy) or in response to chronic irritation (cervicitis, trauma from childbirth), the columnar epithelium that is exposed on the ectocervix undergoes squamous metaplasia, meaning the columnar cells are gradually replaced by squamous epithelium. This is a normal, physiologic process.

The problem arises when the newly formed squamous epithelium grows over and occludes the openings of the endocervical glands before they stop secreting mucus. The glands continue to produce mucin, but the outflow tract is now sealed. Mucus accumulates within the gland, distending it and forming a mucus-filled retention cyst. This is a Nabothian cyst.

This explains why Nabothian cysts are so common in multiparous women (repeated cervical trauma from delivery accelerates metaplasia) and in postmenopausal women (the SCJ recedes into the canal, and the transformation zone undergoes further metaplastic change). It also explains why the cysts are completely benign: the underlying process is normal squamous metaplasia, not dysplasia or neoplasia. There is no malignant potential.

The cysts are usually small (a few millimeters) because the gland eventually stops secreting and the cyst stabilizes. Rarely, a cyst can enlarge to several centimeters ("giant Nabothian cyst"), at which point it may cause mechanical symptoms such as vaginal fullness or obstruction of the cervical canal.

02Classification and Clinical Manifestation

Nabothian cysts do not have a formal clinical classification system, but they can be categorized by size and presentation for exam purposes:

Most exam questions will test the typical presentation: an asymptomatic, incidentally found cervical cyst that requires only reassurance.

03Diagnostic Workup

In the vast majority of cases, Nabothian cysts are a clinical diagnosis. When a clinician performs a speculum exam and sees one or more small, smooth, round, translucent or whitish-yellow bumps on the cervix that are non-tender and non-bleeding, the diagnosis is made on the spot. No imaging, no biopsy, no labs.

The question of further workup arises only in two scenarios:

Scenario 1: The cyst is unusually large. A giant Nabothian cyst (greater than 4 cm) can distort the cervical anatomy and raise concern for a cervical mass. In this situation, transvaginal ultrasound is the best initial imaging study. The classic ultrasound finding is a well-circumscribed, anechoic cyst within the cervical stroma with no solid component and no internal blood flow on color Doppler. If the ultrasound is indeterminate, MRI is the next step. On MRI, Nabothian cysts are characteristically hyperintense on T2-weighted sequences (reflecting their mucin content) and show no enhancement after gadolinium contrast, confirming their benign, cystic nature.

Scenario 2: Concern for adenoma malignum. This is the most important diagnostic pitfall. Adenoma malignum (minimal deviation adenocarcinoma of the cervix) is a rare but aggressive subtype of cervical adenocarcinoma that can present as multiple deep cysts within the cervical stroma, mimicking Nabothian cysts on imaging. On MRI, the distinguishing features of adenoma malignum include cysts of varying sizes arranged in a "cosmos" pattern, solid enhancing components, and irregular stromal infiltration. If there is any suspicion, biopsy is required.

There are no laboratory tests indicated for Nabothian cysts. Pap smear and HPV testing follow routine cervical cancer screening guidelines and are not ordered because of a Nabothian cyst.

04Management and Treatment

The single most tested concept in exam questions about Nabothian cysts is that no treatment is necessary. The correct answer in nearly every clinical scenario involving a classic Nabothian cyst is reassurance and observation.

These cysts have no malignant potential. They do not grow progressively. They do not interfere with fertility, pregnancy, or cervical cancer screening. They are not a precursor to any pathologic condition.

For the rare patient who has a symptomatic cyst (e.g., profuse mucoid discharge from a ruptured cyst, dyspareunia from a large cyst, or cervical canal obstruction), simple office-based procedures can be performed. Electrocautery or cryotherapy can ablate the cyst. Alternatively, needle aspiration can decompress it, though recurrence is possible because the underlying gland may re-accumulate mucus.

For giant Nabothian cysts (reported cases up to 7 to 8 cm), marsupialization or formal surgical excision may be necessary. These cases are rare and unlikely to appear as a management question on the exam. If they do, the tested concept is the need to exclude cervical malignancy before proceeding.

There are no medications, no antibiotics, and no hormonal therapies indicated for Nabothian cysts. If a vignette includes antibiotics as a treatment option for a cervical cyst that is clearly described as a Nabothian cyst, that answer is incorrect.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on Nabothian cyst questions is by overtreating or over-investigating a benign finding. When a vignette describes a reproductive-age woman with an incidental, small, smooth, translucent cervical cyst found on routine pelvic exam, the correct answer is almost always reassurance. Students who select biopsy, ultrasound, or referral for these classic presentations are falling into the trap of treating normal anatomy as pathology.

The second trap involves confusing Nabothian cysts with adenoma malignum when the vignette describes multiple deep cervical cysts, especially in a patient with profuse watery discharge. This is the one scenario where further workup is warranted. The tested skill here is recognizing that while a solitary superficial cervical cyst is benign, multiple deep cysts with atypical features should raise suspicion for a rare but dangerous malignancy.

A third, more subtle trap is location confusion. Students sometimes confuse Nabothian cysts (cervix) with Bartholin cysts (vulva/introitus) or Gartner duct cysts (vaginal wall). The vignette will always specify the anatomic location. Reading this detail carefully prevents selecting the wrong diagnosis.

The core competency being tested with Nabothian cysts is the ability to recognize a benign, incidental finding and avoid unnecessary intervention. This is a recurring theme across the exam: not every abnormality requires treatment, and the best physicians know when to leave things alone.